On September 26, 2018 Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage oncology company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer, reported that its management will provide a corporate update at the forthcoming Ladenburg Thalmann 2018 Healthcare Conference and Cantor Global Healthcare Conference, both in New York City (Press release, Molecular Templates, SEP 26, 2018, View Source [SID1234529617]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Ladenburg Thalmann Presentation Details
Date: Tuesday, October 2
Time: 9:30am Eastern Time
Location: Sofitel New York Hotel
Webcast: View Source

Cantor Presentation Details
Date: Wednesday, October 3
Time: 1:05pm Eastern Time
Location: InterContinental New York Barclay Hotel